Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2004-11-04
2009-08-04
Shibuya, Mark L (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C435S007910, C435S007920
Reexamination Certificate
active
07569353
ABSTRACT:
The present invention relates to the diagnosis of hematopoietic disorders and to determining the prognosis of patients affected by such disorders. The methods generally comprise determining a level of myeloperoxidase in a body fluid sample from the individual and using the level as a factor for diagnosing the disorder in the mammal or as a factor for determining the prognosis of a patient diagnosed with such a disorder. Myelodysplastic syndrome, acute myeloid leukemia and chronic myeloid leukemia are exemplary disorders. Also provided are method of cancer therapy involving reducing the level of myeloperoxidase in the body fluid of the individual.
REFERENCES:
patent: 4614513 (1986-09-01), Bensinger
patent: 4637880 (1987-01-01), Halbert
patent: 4685900 (1987-08-01), Honard et al.
patent: 5200319 (1993-04-01), Arnaout et al.
patent: 6569112 (2003-05-01), Strahilevitz
patent: 6599713 (2003-07-01), Hatanaka et al.
patent: 2006/0035308 (2006-02-01), Yuan et al.
Oberg et al. (Eur. J Haematol 1987 vol. 38: 148-155).
Malmquist et al. (Scand. J. Haemat. 1972, vol. 9, p. 311-317).
Giles et. al., A prognostic model for survival in chronic lymphocytic leukemia based on p53 expression. British Journal of Hemotology, 121:578-585.
Kamik et al., Use of polyclonal anti-myeloperoxidase antibody in myeloid lineage determination. Indian J Med Res. 100: 272-6, Dec. 1994.
Matsuo et al., The percentage of myeloperoxidase-positive blast cells is a strong independent prognostic factor in acute myeloid leukemia, even in the patients with normal karyotype. Leukemia, 17:1538-1543, 2003.
Cheu Jacob
Foley and Lardner LLP
Quest Diagnostics Investments Incorporated
Shibuya Mark L
LandOfFree
Myeloperoxidase detection in diagnosis and prognosis of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Myeloperoxidase detection in diagnosis and prognosis of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Myeloperoxidase detection in diagnosis and prognosis of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4070011